Why Drug Companies Are Rushing to Market Ketamine Medicines NYT - Science By: Andrew Jacobs 21 October 2026 at 13:41 Spurred on by the Trump administrationβs embrace of psychedelic medicine, researchers are experimenting with new β and not so new β forms of the anesthetic.
Psilocybin May Prevent Nerve Damage Caused by Chemotherapy, Study Finds NYT - Science By: Andrew Jacobs 3 September 2026 at 22:46 The preliminary research was conducted in mice, but scientists were optimistic the results would apply to humans. Clinical trials begin this month.